I 
117TH CONGRESS 
2D SESSION 
H. R. 7658 
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the 
Critical Path Public-Private Partnerships. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 3, 2022 
Mr. O’HALLERAN (for himself and Mrs. LESKO) introduced the following bill; 
which was referred to the Committee on Energy and Commerce 
A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
reauthorize the Critical Path Public-Private Partnerships. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. REAUTHORIZATION OF THE CRITICAL PATH 
3
PUBLIC-PRIVATE PARTNERSHIPS. 
4
Section 566(f) of the Federal Food, Drug, and Cos-
5
metic Act (21 U.S.C. 360bbb–5(f)) is amended by striking 
6
‘‘$6,000,000 for each of fiscal years 2018 through 2022’’ 
7
and inserting ‘‘$10,000,000 for each of fiscal years 2023 
8
through 2027’’. 
9
Æ 
VerDate Sep 11 2014 
03:51 May 04, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6301
E:\BILLS\H7658.IH
H7658
kjohnson on DSK79L0C42PROD with BILLS
